The Wolf Hall trilogy concludes
Days : Hours : Minutes : Seconds
The Ambivalence of Cytostatic Therapy - Recent Results in Cancer Research 52 (Hardback)
  • The Ambivalence of Cytostatic Therapy - Recent Results in Cancer Research 52 (Hardback)
zoom

The Ambivalence of Cytostatic Therapy - Recent Results in Cancer Research 52 (Hardback)

(editor), (editor)
£72.00
Hardback 246 Pages / Published: 01/10/1975
  • Not available

This product is currently unavailable

This product is currently unavailable.

  • This item has been added to your basket
E. GRUNDMANN The question as to whether cytostatic drugs might be carcinogenic has been presented and discussed in three experimental studies. The most extensive in- vestigations were by J. H. WEISBURGER and coll. (New York, Alabama, Bethesda). They started with an exact determination of rate and localization for spon- . taneous tumors in their animal strains. Thirteen cytostatic compounds current- ly in clinical use were then given in the maximally tolerated dose (MTD) to groups of 25 male and 25 female animals (rats and mice) three times weekly, in most assays over a period of 6 months. Other identical groups of animals received 0. 5 of the MTD. Each test involved 50 male and 50 female mice and the same number of rats. As positive controls, identical groups were given diethylnitrosamine, which induced tumors of liver, lungs and kidneys in the expected rates. The direct alkylating agents (Actinomycin 0, Melphalan, Mito- mycin 0, Uracil mustard, Dibromomannitol and Dibromodulcitol) induced cancer in the peritoneal cavity, the site of the injections. Rats appeared to be more susceptible than mice. Other drugs (e. g. the cyclohexamide salt of phos- phorodiamidic acid derivative, Natulan, DIC and streptozotocin) had a broad spectrum of carcinogenicity affecting a variety of organs. Several agents led to tumors in the hematopoietic and lymphatic systems in mice or rats or both. The correlation to the general immunosuppressive action is not quite clear. 6-Mercaptopurine induces lymphosarcomas in mice.

Publisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG
ISBN: 9783540072409
Number of pages: 246
Weight: 650 g

You may also be interested in...

When I Die
Added to basket
£8.99
Paperback
Oxford Handbook of Oncology
Added to basket
Mum's Not Having Chemo
Added to basket
The Cancer Chronicles
Added to basket
The Chemotherapy Survival Guide
Added to basket
Radical Remission
Added to basket
Beat Cancer
Added to basket
£14.99
Paperback
C List
Added to basket
£10.99
Paperback
Cancer Care
Added to basket
£8.99
Paperback
Cancer Virus
Added to basket
Laws of Medicine
Added to basket
The Emperor of All Maladies
Added to basket
Medicine Hands
Added to basket
£29.99
Paperback
Cancer: A Very Short Introduction
Added to basket

Please sign in to write a review

Your review has been submitted successfully.